Revlimid, which is approved for multiple myeloma patients in combination with the steroid dexamethasone, and for a rare condition called myelodysplastic syndromes, had revenue of $1.7 billion in 2009.

Revlimid和类固醇地塞米松联合用药被批准用于多发性脊髓瘤和罕见病 骨髓增生异常综合征 的治疗。 其2009年的销售额为17亿美元。

youdao

Objective To explore an effective method in acne treatment by means of combination of diseases differentiation and syndromes differentiation.

目的：客观评价辨病与辨证相结合治疗强直性脊柱炎的临床疗效及安全性。

youdao

Objective To explore an effective method in acne treatment by means of combination of diseases differentiation and syndromes differentiation.

目的探索中医辨病辨证相结合治疗痤疮的有效方法。

youdao